Philip Ashton-Rickardt

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Ashton-Rickardt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 0 $0.7500 11 Aug 2023 Direct

Insider Reports Filed by Philip Ashton-Rickardt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588923012129-ashton-rickardt-philip-2023-08-11 Sigilon Therapeutics, Inc. 11 Aug 2023 1 -$6,634 4 CHIEF SCIENTIFIC OFFICER 11 Aug 2023, 16:10
/report/000141588923003675-ashton-rickardt-philip-2023-02-28 Sigilon Therapeutics, Inc. 28 Feb 2023 1 $0 4 CHIEF SCIENTIFIC OFFICER 01 Mar 2023, 15:38
/report/000141588922001635-ashton-rickardt-philip-2022-02-18 Sigilon Therapeutics, Inc. 18 Feb 2022 1 +$133,200 4 CHIEF SCIENTIFIC OFFICER 22 Feb 2022, 16:01
/report/000141588922000195-ashton-rickardt-philip-2022-01-03 Sigilon Therapeutics, Inc. 03 Jan 2022 1 +$272,700 4 CHIEF SCIENTIFIC OFFICER 04 Jan 2022, 15:15
/report/000141588921003390-ashton-rickardt-philip-2021-07-01 Sigilon Therapeutics, Inc. 01 Jul 2021 1 $0 4 CHIEF SCIENTIFIC OFFICER 02 Jul 2021, 16:10
/report/000141588921002992-ashton-rickardt-philip-2021-06-14 Sigilon Therapeutics, Inc. 14 Jun 2021 0 $0 3 Chief Scientific Officer 14 Jun 2021, 17:10